Susan Altschuller | Vice President, Investor Relations |
Ludwig Hantson | CEO |
Paul Clancy | Chief Financial Officer |
John Orloff | Global Head of R&D |
Brian Goff | Chief Commercial Officer |
Aradhana Sarin | Chief Strategy and Business Officer and Incoming CFO |
Josh Schimmer | Evercore ISI |
Matthew Harrison | Morgan Stanley |
Geoffrey Porges | SVB Leerink |
Chris Raymond | Piper Jaffray |
Phil Nadeau | Cowen & Company |
Geoff Meacham | Bank of America |
Paul Matteis | Stifel |
Mohit Bansal | Citi |
Salveen Richter | Goldman Sachs |
Laura Chico | Wedbush Securities |
Rahul Prasad | William Blair |
Ladies and gentlemen, thank you for standing by and welcome to the Alexion Pharmaceuticals Third Quarter 2019 Results Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference may be recorded.